SANA
SANA BIOTECH (SANA)
NASDAQ
$3.64$0.00 (0.00%)
Price as of Jul 14, 2026 7:01 AM EDT
  • $1.0B
    Market Cap
  • -13.74%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-132.0M
-39.34%
-217.6M
-19.07%
-268.8M
-5.97%
-285.9M
+14.99%
Depreciation and Amortization Expense
0
N/A
0
N/A
0
-100.00%
15.6M
+41.15%
Total Operating Expenses
250.3M
-8.21%
272.7M
-6.97%
293.1M
+7.55%
272.6M
-23.63%
Operating Profit
-250.3M
-8.21%
-272.7M
-6.97%
-293.1M
+7.55%
-272.6M
-23.63%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
2.3M
+151.14%
-4.5M
+8,567.31%
-52,000
-92.28%
-674,000
-320.98%
Income before Taxes
-250.3M
-8.21%
-272.7M
-6.97%
-293.1M
+7.55%
-272.6M
-23.42%
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
44.6M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-244.2M
-8.47%
-266.8M
-5.82%
-283.3M
+5.11%
-269.5M
-24.29%
Net Income from Continuing Operations Applicable to Common
-244.2M
-8.47%
-266.8M
-5.82%
-283.3M
+5.11%
-269.5M
-24.29%
Basic EPS and Net Income
-0.96
-17.24%
-1.16
-20.55%
-1.46
+2.10%
-1.43
-33.18%
Diluted EPS and Net Income
-0.96
-17.24%
-1.16
-20.55%
-1.46
+2.10%
-1.43
-33.18%
Basic Weighted Average Shares
253.2M
+9.68%
230.9M
+18.69%
194.5M
+3.29%
188.3M
+13.17%
Diluted Weighted Average Shares
253.2M
+9.68%
230.9M
+18.69%
194.5M
+3.29%
188.3M
+13.17%
Balance Sheet
Cash and Cash Equivalents
71.9M
-43.66%
127.6M
-4.46%
133.5M
-24.47%
176.8M
-30.14%
Short-Term Investments
66.5M
+166.78%
24.9M
-65.22%
71.7M
-71.00%
247.2M
-17.04%
Cash and Cash Equivalents and Short-Term Investments
138.4M
-9.26%
152.5M
-25.68%
205.2M
-51.60%
424.0M
-23.06%
Total Current Assets
148.7M
-7.54%
160.8M
-24.69%
213.5M
-51.96%
444.4M
-20.37%
Accumulated Depreciation
54.8M
+1.09%
54.2M
+29.67%
41.8M
+22.94%
34.0M
+80.98%
Property and Plant and Equipment and Net
26.9M
-65.20%
77.3M
+9.36%
70.7M
+5.64%
66.9M
+2.22%
Total Long-Term Assets
3.2M
-38.04%
5.1M
-19.61%
6.4M
+38.51%
4.6M
-8.02%
Total Assets
416.9M
-16.79%
501.0M
-11.37%
565.3M
-31.29%
822.7M
-27.15%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
78.7M
+73.28%
45.4M
-29.55%
64.5M
-42.17%
111.5M
+12.36%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
10.6M
+7.11%
9.9M
-89.11%
90.9M
-5.17%
95.9M
+17,651.85%
Total Liabilities
256.0M
+2.19%
250.5M
-9.82%
277.8M
-14.10%
323.4M
-19.33%
Retained Earnings
-1.8B
+15.21%
-1.6B
+19.94%
-1.3B
+26.85%
-1.1B
+34.31%
Total Stockholders Equity
160.9M
-35.78%
250.5M
-12.87%
287.5M
-42.42%
499.3M
-31.46%
Total Shares Outstanding
266.7M
+19.12%
223.9M
+13.17%
197.9M
+3.58%
191.0M
+3.29%
Cash Flow
Cash from Operating Activities
-143.8M
-35.55%
-223.2M
-12.00%
-253.6M
-12.57%
-290.1M
+15.53%
Capital Expenditures
938,000
-97.19%
33.4M
+66.88%
20.0M
-4.04%
20.9M
-30.09%
Cash from Investing Activities
-40.2M
-330.55%
17.5M
-89.85%
172.0M
-18.31%
210.6M
+185.66%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
128.7M
-35.55%
199.7M
+531.20%
31.6M
+544.13%
4.9M
-99.22%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-53.20%
+6.33%
-50.03%
+22.59%
-40.81%
+47.83%
-27.61%
N/A
Return on Equity
-118.70%
+19.70%
-99.17%
+37.73%
-72.00%
+64.03%
-43.90%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.89
-46.65%
3.54
+6.90%
3.31
-16.93%
3.99
N/A
Cash Ratio
0.91
-67.49%
2.81
+35.62%
2.07
+30.60%
1.59
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow